Company Summary

Quicksilver Biosciences is developing a rapid, point-of-care diagnostic tool that can identify a vast array of analytes with unprecedented single-molecule precision.

Year Founded:  2018

Key Executives:
• Erik Young, CEO

Location:  New York, NY

Website:  https://www.quicksilverbiosciences.com/

Company Status:   Private

Year Invested:  2018

Investment Status:  Current

Board Member:
Josh Palmer